MBOT: Microbot Medical Inc Price Target Chart

Corporate company logo of Microbot Medical, Inc. (MBOT)

Microbot Medical Inc. (MBOT) positions itself as a visionary in the development of microrobots for safe vascular interventions. The business currently relies on the testing stage, resulting in a lack of profit and a financial position of 5.38 due to R&D expenditures. Expanding system functionality for neurosurgery and entering global markets mitigates regional risks. This price chart is available on GURU.Markets.

MBOT Microbot Medical, Inc Consensus Target (07/04/2022 - 11/12/2026)

Analytical breakdowns for Microbot Medical Inc (MBOT)

- market price and analyst price targets:
Stock Quotes microbotmedical.com|MBOT - Analyst Consensus Forecast
- market capitalization information:
Market Value Microbot Medical Inc|MBOT - Total Company Value
- issuer book value statistics:
Net Asset Value per Share Microbot Medical|MBOT - Company Net Assets|Market Cap to Book Value Multiple microbotmedical.com|MBOT - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Microbot Medical Inc.|MBOT - Long-Term Debt to Capital|Current Liabilities to Capital Microbot Medical, Inc|MBOT - Company Aggregate Debts|Debt to Book Value Ratio Microbot Medical Inc|MBOT - Company Long-Term Debts|Short-Term Debt Volume Microbot Medical|Quick Liquidity Indicator microbotmedical.com
- earnings and multiples data:
MBOT - Net Profit|Projected Future Earnings Microbot Medical Inc.|MBOT - Price to Earnings Ratio|Future Price to Earnings Microbot Medical, Inc.|MBOT - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Microbot Medical Inc|MBOT - Operating profit EBITDA|Net earnings per share for the last four quarters Microbot Medical|MBOT - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months microbotmedical.com|MBOT - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Microbot Medical Inc.
General company analysis:microbotmedical.com (MBOT)
Original product of Microbot Medical

Reducing investment risks requires monitoring the dynamics of institutional confidence, particularly for Microbot Medical Inc. (MBOT), whose value is based on the inelastic demand for Liberty disposable robotic systems. The consensus valuation aggregates expert forecasts, reflecting the business's actual market value and signaling potential prolonged capital drawdowns in the event of consistent target price reductions.

Competing companies

Consensus Target intuitive.com ISRG|Analyst Consensus Forecast DHR (Danaher)|BD - Price Target Chart|STE - Price Target Chart|Average Forecast Price West Pharma Corp|BAX (Baxter International) - Consensus Target|MASI: Analyst Forecast Prices|Price Target Chart Stevanato Group|Consensus Target Teleflex Inc. (TFX)|Analyst Consensus Forecast MMSI|NVST - Average Forecast Price|Analyst Consensus Forecast ICUI (ICU Medical, Inc.)|XRAY: Broker Consensus Forecast|LeMaitre Vascular - Analyst Consensus Forecast|Analyst Median Target AtriCure Inc ATRC|STAA: Analyst Consensus Forecast|Consensus Target ChromaDex Corp.|ZIMV (ZimVie Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast angiodynamics.com|Price Target Chart Cerus (CERS)|Price Target Chart TKNO (Alpha Teknova)|Monogram Technologies Inc - Consensus Target|Fair Value Consensus STSS|InfuSystem Inc - Analyst Consensus Forecast|Analyst Median Target utahmed.com UTMD|korumedical.com (KRMD) - Price Target Chart|Broker Consensus Forecast NYXH|Price Target Chart Pro-Dex Corp|Zentek Corp (ZTEK) - Analyst Median Target|Consensus Target ELUT (Elutia Inc.)|Analyst Forecast Prices MLSS|Price Target Chart NEXGEL NXGL|Fair Value Consensus RVP|HBIO: Consensus Target|FEMY - Analyst Consensus Forecast|meihuamed.com (MHUA) - Price Target Chart|Consensus Target Predictive Oncology Inc.|CJMB (Callan JMB Inc.) - Analyst Consensus Forecast|Average Forecast Price Atrion Corp. ATRI|Price Target Chart NeuroMetrix Corp (NURO)